ArticleBrazilian dental journal2025
Platelet-Rich Fibrin Low-Speed Centrifugation Protocols and Particulate Bovine Bone on Bone Defects Repair.
Article in Brazilian dental journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Platelet-rich fibrin (PRF) membranes and injectable PRF (i-PRF) are biological agents used to enhance healing, often combined with deproteinized bovine bone mineral (DBBM) for bone regeneration. This study evaluated low-speed centrifugation protocols for the preparation of PRF membranes and i-PRF combined with DBBM (sticky bone, SB) in repairing rat tibial bone defects. Sixty-four rats received tibial defects filled with blood clot (CO), PRF membrane alone (PRF), DBBM alone (BO), or i-PRF associated with DBBM (SB). Micro-computed tomography (μCT), histological analysis, and gene expression of molecular markers were assessed at 15 and 45 days. PRF membranes led to greater early bone formation and elevated Bglap expression compared to control (p < 0.05). μCT analysis showed that the BO group had significantly greater cortical bone formation at 15 days than the control group (p < 0.05). Additionally, both BO and SB groups promoted increased cortical bone formation at 45 days (p < 0.05), with SB also enhancing cortical thickness at the defect margins. In the medullary region, both BO and SB exhibited higher bone formation and trabecular number (p < 0.05) after 15 and 45 days. Gene expression analysis revealed higher levels of Alpl, Bglap, and Runx2 in the BO group than in SB and control groups (p < 0.05). In conclusion, PRF membranes improved early bone formation compared to a blood clot. DBBM, whether used alone or in combination with i-PRF, also enhanced bone regeneration compared to control. However, the addition of i-PRF did not improve the regenerative potential of DBBM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.